Latest filings (excl ownership)
PRE 14A
Preliminary proxy
26 Apr 24
POS AM
Prospectus update (post-effective amendment)
25 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
19 Apr 24
8-K
Entry into a Material Definitive Agreement
17 Apr 24
424B4
Prospectus supplement with pricing info
5 Apr 24
EFFECT
Notice of effectiveness
2 Apr 24
8-K
Entry into a Material Definitive Agreement
26 Mar 24
DEFA14A
Additional proxy soliciting materials
25 Mar 24
S-1/A
IPO registration (amended)
22 Mar 24
10-K/A
2023 FY
Annual report (amended)
14 Mar 24
DEFA14A
Additional proxy soliciting materials
14 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
14 Mar 24
8-K
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
14 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
8-K/A
Entry into a Material Definitive Agreement
29 Feb 24
8-K/A
Entry into a Material Definitive Agreement
29 Feb 24
S-1/A
IPO registration (amended)
16 Feb 24
S-1/A
IPO registration (amended)
9 Feb 24
8-K
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
8 Feb 24
8-K/A
Report of Independent Registered Public Accounting Firm
26 Jan 24
8-K/A
Entry into a Material Definitive Agreement
17 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
17 Jan 24
8-K
Entry into a Material Definitive Agreement
17 Jan 24
S-1
IPO registration
12 Jan 24
DEF 14A
Definitive proxy
29 Dec 23
PRE 14A
Preliminary proxy
15 Dec 23
8-K
Entry into a Material Definitive Agreement
20 Nov 23
424B4
Prospectus supplement with pricing info
17 Nov 23
424B3
Prospectus supplement
17 Nov 23
424B4
Prospectus supplement with pricing info
17 Nov 23
8-K
Entry into a Material Definitive Agreement
16 Nov 23
8-K
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
15 Nov 23
10-Q
2023 Q3
Quarterly report
15 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
8-K
Entry into a Material Definitive Agreement
13 Sep 23
8-K/A
Entry into a Material Definitive Agreement
6 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
31 Aug 23
424B4
Prospectus supplement with pricing info
17 Aug 23
424B3
Prospectus supplement
17 Aug 23
424B4
Prospectus supplement with pricing info
17 Aug 23
Latest ownership filings
SC 13G/A
Lind Global Fund II LP
13 Feb 24
SC 13G
Lind Global Fund II LP
7 Aug 23
3
Shuling Jiang
12 Jul 22
SC 13D
Jiang Shuling
12 Jul 22
3
Chihliang An
31 Mar 22
3
Norimi Sakamoto
10 Dec 21
3
Yoshinobu Odaira
10 Dec 21
3
Tsung Shann Jiang
15 Nov 21
3
Shin-Yu Miao
15 Nov 21
3
Shih-Chen Tseng
15 Nov 21
3
Eugene Jiang
15 Nov 21
3
Chang-Jen Jiang
15 Nov 21
3
Chi-Hsin Richard King
5 Nov 21
3
Yen-Hsin Chou
5 Nov 21
3
Howard Doong
5 Nov 21
3
Tsang Ming Jiang
26 Oct 21
3
Shulamit Lazar
8 Sep 15
SC 13D
Bonner John
30 Sep 11
SC 13D
Fairmount Five, LLC
22 Sep 11
SC 13D
Equity 11, Ltd.
19 Jan 10